Brought to you by

Novartis pays $2.8bn for 20% of Roche's voting shares
25 Feb 2002
Executive Summary
Novartis has purchased 32mm voting shares of Roche at $87.36 each (SFr151)--a (pr)5% premium-- from BZ Group Holdings for a total of $2.8bn (SFr4.83bn).
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com